Often used for:
Basal cell carcinoma, Medulloblastoma (SHH subtype)
Vismodegib is a type of medicine called a targeted therapy. This medicine is a hedgehog pathway inhibitor. It acts to block certain cell signals to help keep cells from growing.
Female patients of childbearing age will be given a pregnancy test before starting this medicine. Patients will have regular blood draws to monitor blood counts and metabolic function.
May be taken as a capsule by mouth
Not all patients who take vismodegib will experience these side effects. Common side effects are in bold, but there may be others. Please report all suspected side effects to your doctor or pharmacist.
Some patients may experience long-term or late effects of treatment that may continue or develop months or years after treatment ends. Possible late effects due to vismodegib include:
Be sure to discuss these and other recommendations with your doctor or pharmacist.